These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [New trends in adjuvant chemotherapy for non-small-cell lung cancer]. Dediu M; Alexandru A; Median D; Vremeş G Pneumologia; 2005; 54(2):89-93. PubMed ID: 16536008 [No Abstract] [Full Text] [Related]
15. Pemetrexed plus bevacizumab for second-line therapy of non-small-cell lung cancer: the importance of patient selection. Araujo AM J Clin Oncol; 2010 Mar; 28(8):e131; author reply e132. PubMed ID: 20100954 [No Abstract] [Full Text] [Related]
16. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure? Socinski MA J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913 [No Abstract] [Full Text] [Related]
17. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers]. Le Chevalier T Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932 [No Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process. De Pas T; de Braud F; Veronesi G J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773 [No Abstract] [Full Text] [Related]